药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Prednicarbate
Deflazacort
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Deflazacort.
Prednicarbate
Melengestrol
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Melengestrol.
Prednicarbate
Dexamethasone isonicotinate
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Dexamethasone isonicotinate.
Prednicarbate
Meprednisone
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Meprednisone.
Prednicarbate
Fluprednisolone
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Fluprednisolone.
Prednicarbate
Tixocortol
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Tixocortol.
Prednicarbate
Fluprednidene
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Fluprednidene.
Prednicarbate
Fluticasone furoate
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Fluticasone furoate.
Prednicarbate
Ciclesonide
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Ciclesonide.
Prednicarbate
Paramethasone
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Paramethasone.
Prednicarbate
Cortisone acetate
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Cortisone acetate.
Prednicarbate
Corticotropin
The risk or severity of edema formation can be increased when Prasterone sulfate is combined with Corticotropin.
Prednicarbate
Pralsetinib
Pralsetinib may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.
Prednicarbate
Valinomycin
Valinomycin may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.
Prednicarbate
Letermovir
Letermovir may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.
Prednicarbate
Lenvatinib
Lenvatinib may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.
Prednicarbate
Simeprevir
Simeprevir may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level.
Econazole
Imlifidase
The therapeutic efficacy of Trastuzumab emtansine can be decreased when used in combination with Imlifidase.
Econazole
Berotralstat
The serum concentration of Trastuzumab emtansine can be increased when it is combined with Berotralstat.
Econazole
Filgotinib
The serum concentration of Trastuzumab emtansine can be increased when it is combined with Filgotinib.